ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,862 | -2.9% | 5,950 | +52.2% | 0.00% | – |
| Q2 2023 | $19,433 | +16.2% | 3,910 | +15.5% | 0.00% | – |
| Q1 2023 | $16,722 | +368.0% | 3,385 | +496.0% | 0.00% | – |
| Q4 2022 | $3,573 | -87.2% | 568 | -77.9% | 0.00% | -100.0% |
| Q3 2022 | $28,000 | -3.4% | 2,569 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | +262.5% | 2,569 | +198.7% | 0.00% | – |
| Q1 2022 | $8,000 | – | 860 | +2865.5% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 29 | -71.0% | 0.00% | – |
| Q3 2021 | $3,000 | +200.0% | 100 | +233.3% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 30 | +11.1% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 27 | -35.7% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 42 | -68.2% | 0.00% | – |
| Q1 2020 | $3,000 | – | 132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |